Your session is about to expire
← Back to Search
Cisplatin for Non-Small Cell Lung Cancer
Study Summary
This trial is testing a new immunotherapy drug, M7824, to see if it is safe and effective when used with standard chemotherapy and radiation therapy to treat people with cancer.
- Non-Small Cell Lung Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA sanctioned Cisplatin for medical utilization?
"The safety of Cisplatin has been evaluated as a 2 on the 1 to 3 scale. This is because, while there is some data affirming its security profile, it lacks clinical evidence demonstrating efficacy at this stage in development."
In what circumstances is Cisplatin typically recommended?
"Cisplatin is a popular remedy for metastatic ureter urothelial carcinoma, but it also has applications in the treatment of lymphoma, non-Hodgkin's Merkle cell cancer, and locally advanced cases of non-small cell lung cancer."
Is this research endeavor actively seeking participants?
"Clinicialtrials.gov's data shows that, as of October 7th 2021, this trial is no longer actively recruiting patients. It first opened for enrollment on April 16th 2019 and has since not been updated. However, there are 3,886 other studies currently seeking volunteers to join trials around the world."
How many healthcare centers are facilitating this clinical experiment?
"BC Cancer Agency Centre for the Southern Interior in Kelowna, Mayo Clinic Rochester and Holy Cross Hospital - Michael & Dianne Bienes CCC in Fort Lauderdale are some of 22 sites involved with this trial."
How many volunteers are involved in this experiment?
"Unfortunately, this trial is no longer receiving new participants. It was first announced on April 16th 2019 and the last update took place October 7th 2021. Nevertheless, there are currently 1949 active studies for people with carcinoma non-small cell lung cancer and 1937 trials recruiting patients who use Cisplatin."
Has Cisplatin been studied for any other medical purposes?
"The City of Hope Comprehensive Cancer Center first undertook a study on cisplatin back in 1997. Since then, there have been over 21006 completed studies and 1937 trials that are still underway - many of these happening in Kelowna, Minnesota."
Share this study with friends
Copy Link
Messenger